Company Filing History:
Years Active: 2017
Title: Christoph Schmidt: Innovator in Complement Regulation
Introduction
Christoph Schmidt is a notable inventor based in Laugna, Germany. He has made significant contributions to the field of complement regulation, which plays a crucial role in the immune response. His innovative work has led to the development of a unique patent that addresses important aspects of complement activation.
Latest Patents
Schmidt holds a patent titled "Regulator of complement activation and uses thereof." This patent discloses a potent complement regulator that comprises a complement regulatory region connected by a flexible linker to a multifunctional binding region. This design enables binding to C3b activation/inactivation products and/or oxidation end products, as well as to polyanionic surface markers on host cells. An embodiment of the invention utilizes factor H SCRs 1-4 as the complement regulatory region and factor H SCRs 19 and 20 as the multifunctional binding region, linked together by a poly-Gly linker at least 12 residues in length. The patent also includes pharmaceutical compositions comprising the complement regulator and methods of using the complement regulator.
Career Highlights
Christoph Schmidt is affiliated with the University of Pennsylvania, where he continues to advance research in his field. His work has garnered attention for its potential applications in therapeutic settings, particularly in the modulation of immune responses.
Collaborations
Schmidt has collaborated with esteemed colleagues, including John D. Lambris and Daniel Ricklin. These partnerships have further enriched his research and contributed to the development of innovative solutions in complement regulation.
Conclusion
Christoph Schmidt's contributions to the field of complement regulation exemplify the impact of innovative thinking in scientific research. His patent and ongoing work at the University of Pennsylvania highlight the importance of collaboration and creativity in advancing medical science.